Adding corticosteroids to galcanezumab in medication overuse headache: A three-arm head-to-head prospective observational cohort study.

Rev Neurol (Paris)

Department of Neurological Sciences, Reproductive and Odontostomatological Sciences, University Federico II, 80131 Naples, Italy. Electronic address:

Published: November 2024

AI Article Synopsis

  • MOH (Medication Overuse Headache) can occur from excessive pain relief medication use, but anti-CGRP monoclonal antibodies like galcanezumab have shown promise as preventive treatments.
  • A study involving 75 patients compared the effectiveness and safety of galcanezumab alone, galcanezumab with prednisone, and prednisone alone over a 3-month period.
  • All treatments reduced headache frequency significantly, but the galcanezumab combined with prednisone resulted in the greatest reduction; however, prednisone had more side effects, suggesting its use should be limited to cases unresponsive to other treatments.

Article Abstract

Background: Medication overuse headache (MOH) is a condition where pain relief medications cause chronic headaches due to excessive use. Recent advancements highlight the effectiveness of preventive treatments like anti-CGRP monoclonal antibodies. Current strategies combine medication withdrawal and preventive treatments, with corticosteroids traditionally used to ease withdrawal symptoms.

Methods: This is a prospective three-arm observational cohort study comparing the effectiveness and safety of galcanezumab alone, galcanezumab plus prednisone and prednisone alone for the treatment of MOH. We enrolled 75 patients. Prednisone was administered at an initial dose of 50mg daily, and then tapered off over 28days. Duration of follow-up was 3months.

Results: All treatments proved effective (P<0.001). We found a significant reduction of mean monthly days with headache in the galcanezumab plus prednisone group (baseline: 25, IQR: 20-30; after 3months: 7, IQR: 5-10), in the galcanezumab group (baseline: 25, IQR: 20-30; after 3months: 10, IQR: 5-14) and in the Prednisone group (baseline: 25, IQR: 20-28; after 3months: median: 15 days, IQR: 8-22days). Patients treated with prednisone reported a higher incidence of side effects (P=0.002).

Conclusion: Our study indicates that both galcanezumab and prednisone decrease the frequency of headaches in patients with MOH. The combined usage of these treatments showed the highest reduction in mean monthly headache days. However, treatment with prednisone determined a significant rate of adverse events, therefore we suggest its use only in unresponsive patients. In all other patients galcanezumab appears to be a safe and effective option.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neurol.2024.10.003DOI Listing

Publication Analysis

Top Keywords

medication overuse
8
overuse headache
8
observational cohort
8
cohort study
8
preventive treatments
8
adding corticosteroids
4
corticosteroids galcanezumab
4
galcanezumab medication
4
headache three-arm
4
three-arm head-to-head
4

Similar Publications

Background: We have previously shown headache disorders to be prevalent in in the adult general population of Morocco, especially migraine (30.8%) and headache on ≥ 15 days/month (H15+; 10.5%).

View Article and Find Full Text PDF

Background: Endodontic emergencies, often presented as acute pain or swelling, constitute a substantial challenge in dental practice. While effective management emphasizes prompt intervention, antibiotics are typically indicated only when systemic signs and symptoms are present. There is limited research exists on evaluating the knowledge and clinical approach of dental practitioners in managing endodontic emergencies from our region of the world.

View Article and Find Full Text PDF

Antibiotic Utilization and Its Implications Among Ruminant Farmers and Stakeholders in Sumbawa Regency, Indonesia.

Vet Med Int

December 2024

Department of Resource and Environmental Economics, Faculty of Economics and Management, IPB University, Bogor, West Java, Indonesia.

The rise in antimicrobial resistance is a vital concern, and various factors, such as the overuse of antibiotics in agriculture, have contributed to its development and spread. Livestock farmers, veterinarians, and pharmacies are key prescribers of antibiotics for disease prevention, control, and treatment of ruminant animals. A qualitative study in the Sumbawa District examined their awareness, attitudes, and practices concerning antibiotic use, residues, and resistance, underscoring their vital role in tackling this challenge.

View Article and Find Full Text PDF

Prescription opioids continue to be commonly used for chronic non-cancer pain, despite inherent risks. Primary care physicians and advanced practice clinicians have been integral to driving change in opioid prescribing, preventing overuse, and reducing risk. The authors of this article assessed the current extent of opioid prescribing using publicly available data to identify which specialties are most likely to prescribe opioids and to what extent.

View Article and Find Full Text PDF

Background: Antimicrobial misuse and overuse propagate antimicrobial resistance, yet data on factors influencing antibiotic prescription decisions in low-resource settings are limited. We describe factors influencing antimicrobial prescription at a large tertiary care private not-for-profit hospital in Uganda.

Methods: We conducted a descriptive phenomenology qualitative study involving face-to-face in-depth interviews of 12 purposively selected prescribers (four intern doctors, six medical officers and two Internal Medicine physicians) in a private not-for-profit hospital in Kampala, Uganda.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!